Price trends of reimbursed oncological drugs in Switzerland in 2005–2019: A descriptive analysis

• Yael Rachamin ,

  Contributed equally to this work with: Yael Rachamin, Thomas Grischott

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Institute of Primary Care, University of Zurich and University Hospital Zurich, Zurich, Switzerland

  https://orcid.org/0000-0002-1484-6934

  ⨯
• Christoph Jakob Ackermann,

  Roles Conceptualization, Writing – review & editing

  Affiliation Department of Medical Oncology, Spital STS AG, Thun, Switzerland

  ⨯
• Oliver Senn,

  Roles Supervision, Writing – review & editing

  Affiliation Institute of Primary Care, University of Zurich and University Hospital Zurich, Zurich, Switzerland

  https://orcid.org/0000-0003-4422-7250

  ⨯
• Thomas Grischott

  Contributed equally to this work with: Yael Rachamin, Thomas Grischott

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing

  * E-mail: thomas.grischott@usz.ch

  Affiliation Institute of Primary Care, University of Zurich and University Hospital Zurich, Zurich, Switzerland

  https://orcid.org/0000-0002-1564-5296

  ⨯